Site maintenance Wednesday, November 13th, 2024. Please note that access to some content and account information will be unavailable on this date.
Skip to main content

Abstract

Objective:

Specialty addiction programs treat people who are addicted to alcohol, opioids, stimulants, and other drugs. This study identified the proportion of addiction program clients who received tobacco-related services and factors associated with receipt of such services.

Methods:

In 2015 and 2016, clients (N=2,119) in 24 programs were surveyed for receipt of services aligning with three of the five As of tobacco cessation: ask, advise, assist. Multivariate analyses examined factors associated with receipt of each service.

Results:

Most clients (76%) were asked about smoking. Among smokers (N=1,630), 53% were advised to quit, 41% received counseling, 26% received cessation medication, and 17% received counseling and medication. Clients were more likely to receive tobacco-related services if they wanted help quitting smoking or were enrolled in programs with tobacco-free grounds.

Conclusions:

These correlational findings suggest that increasing client motivation to quit and implementing tobacco-free policies on the grounds of treatment centers may increase tobacco-related services in addiction treatment.
HIGHLIGHTS
This study examined factors associated with receipt of tobacco cessation services by clients in addiction treatment programs.
Whether clients wanted to quit smoking and whether addiction treatment programs had tobacco-free grounds were robustly associated with client receipt of tobacco cessation services.
Over 19 million Americans need treatment for abuse of alcohol, illicit drugs, or prescription drugs. Of those, 3.8 million receive addiction treatment annually in self-help settings, primary care, or specialty treatment programs (1). Among persons in addiction treatment, smoking is a prevalent comorbid health risk, with smoking rates consistently above 70% from 1987 through 2015 (2). Addiction treatment services reach 2.85 million smokers annually, or 7.5% of all U.S. smokers (3). The burden of tobacco-related illness is substantial, given that persons receiving addiction treatment are nearly twice as likely to die of tobacco-related causes as those in the general population (4). Many smokers in addiction treatment want to quit smoking (5), and quitting smoking may improve addiction treatment outcomes (6).
These findings have prompted investigators to explore tobacco cessation services in addiction treatment, where barriers to such services include lack of staff training and a culture where smoking is often normalized (6). The five As offer an evidence-based smoking cessation intervention: ask about tobacco use, advise users to quit, assess willingness to make a quit attempt, assist those willing to quit through pharmacotherapy or referring to counseling, and arrange for follow-up one week after the quit date (7).
This brief report describes tobacco cessation services received by clients enrolled in a national sample of 24 addiction treatment programs. We explored whether clients reported being asked, advised, or assisted with smoking cessation in their treatment program and examined factors associated with receipt of those services.

Methods

Twenty-four publicly funded addiction programs participating in the National Institute on Drug Abuse Clinical Trials Network (CTN) were selected in 2013, including seven outpatient, 10 residential, and seven methadone programs. Publicly funded programs receive more than 50% of funding from government sources and serve low-income populations. Methadone programs provide daily on-site methadone administration for opioid use disorder. Nonmethadone outpatient and residential programs typically treat all substance use disorders. Outpatient programs involve one or two visits per week, whereas residential programs involve structured daily treatment with clients living on site (8). Our team visited each program in 2015 and 2016, recruiting up to 50 clients per program per year for an anonymous online survey. The 2015 sample (N=1,125) represented 17% of all 6,801 active clients in these programs when site visits were conducted. The 2016 survey asked participants if they recalled taking the survey in the previous year, to remove probable duplicate cases. All who provided informed consent also completed the survey (N=2,119) and received a $20 gift card. Program directors were interviewed by phone about program tobacco policies. Program selection, participant recruitment, and coding of tobacco-free grounds are reported elsewhere (2). Study procedures were approved by the University of California, San Francisco, Institutional Review Board.
In addition to indicating demographic information, participants provided information for a number of independent variables, including reporting the number of days in the past month when their physical health or mental health was not good (9). Four categories were defined by <14 days of “physical and mental distress” (i.e., low health distress), ≥14 days of “physical health distress,” ≥14 days of “mental health distress,” and ≥14 days of both “physical and mental health distress.” Current smoking was defined as having smoked at least 100 cigarettes in one’s lifetime, and self-reporting as a current smoker (https://www.cdc.gov/nchs/nhis/tobacco/tobacco_glossary.htm). Current smokers reported number of cigarettes smoked per day (CPD) and whether they made a quit attempt in the past year, were thinking of quitting in the next 30 days (10), and wanted help with quitting. Smokers estimated the chance (0%−100%) they would get lung cancer, have trouble catching their breath, or have a heart attack; the mean of these percentages represented perceived health risk of smoking (11). Each survey was coded as to whether the participant’s program had tobacco-free grounds or not.
These independent variables were selected because quit attempts are associated with both readiness to quit and receipt of cessation services in addiction treatment (5), because persons with health concerns are more likely to quit smoking while in addiction treatment (12), and because implementation of tobacco-free grounds is associated with increased cessation services reported by clients (2).
For tobacco service outcomes, clients reported whether any staff member had asked about their smoking or advised them on how to quit smoking. To assess how smokers were assisted with quitting, we used four measures: any referral, any counseling, any medication, and counseling and medication, as recommended by Clinical Practice Guidelines (7). Receipt of a referral to a smoking cessation specialist (yes or no) or to a smoking quitline (yes or no) was coded as having received any referral. Participants who reported having attended a cessation support group (yes or no) or that their counselor encouraged them to quit smoking or arranged an appointment to discuss quitting (responses to both items were never, occasionally, often, very often, or always, dichotomized as no for never or occasionally and yes for the others) were coded as having received any counseling. Receipt of nicotine replacement therapy or other cessation medication (bupropion, varenicline) was coded as having received any medication. Last, we combined the counseling and medication measures to assess the proportion who received this recommended combination of services (7).
Comparing the 2015 and 2016 samples showed few differences on demographic, smoking behavior, or tobacco service measures. Thus, we collapsed responses across time and, using multiple logistic regression, tested factors associated with tobacco service outcomes. We collapsed data across years, and after removing 145 possible duplicate cases and 14 with indeterminate smoking status, we derived a final sample size of 2,119.
The first outcome, whether clients were asked about smoking, included smokers (N=1,633) and nonsmokers (N=486). Smoking variables were not available for nonsmokers, so the model included current smoking status, demographic characteristics (age, gender, race or ethnicity, education, time in treatment, treatment type, and health distress), and tobacco-free grounds status. Analyses accounted for nesting of participants within the program via generalized estimating equation models for correlated data. For the health distress measure, low health distress was used as the referent. The remaining five outcomes applied to smokers only. Each model was the same as the one already described, but without smoking status and with the addition of smoking characteristics (CPD, quit attempt in the past year, thoughts of quitting, health risk perception, wanted help quitting). The rate of missing data was <1% for each independent variable except for health distress (3%) and ≤5% for all multivariate models. Missing data were not expected to affect the results. Analyses were conducted with SAS version 9.4.

Results

Participants (N=2,119) had a mean±SD age of 38.2±11.9, 47% (N=989) were women, and 79% (N=1,666) had a high school diploma or GED. The sample included white (57%, N=1,199), African-American (17%, N=351), and Hispanic (13%, N=282) participants, with fewer persons of Native American (5%, N=102), Asian or Pacific Islander (2%, N=47), or other races or ethnicities (7%, N=138). Most (69%, N=1,425) reported low health distress, whereas fewer reported mental health distress (17%, N=341), physical health distress (4%, N=91), or both (10%, N=197). Participants were recruited from outpatient (31%, N=647), residential (40%, N=854), and methadone (29%, N=618) programs.
Most respondents (77%, N=1,633) were current smokers, consuming 13.2±8.5 CPD. Half (50%, N=878) had made a quit attempt in the past year, and 26% (N=416) were thinking of quitting in the next 30 days. Mean perceived health risk from smoking was 47%±25%. Many (40%, N=714) wanted help with quitting smoking, and 28% (N=584) were in programs that had tobacco-free grounds. The 2016 sample included fewer methadone clients (χ2=7.3, df=2, p=0.026) and reported shorter time in treatment than in 2015 (64.3±146.1 days vs. 86.4±162.8 days; t=3.3, df=2,112, p=0.001), and these variables were included in the analysis.
Most clients (76%, N=1,602) had been asked their smoking status, and among smokers, 53% (N=870) had been advised on how to quit. Smokers reported receiving any referral (46%, N=753), any counseling (41%, N=671), any medication (26%, N=424), and both counseling and medication (17%, N=284).
Participants with both mental and physical health distress had lower odds of referral to tobacco cessation services (odds ratio [OR]=0.69; Table 1). Smokers thinking of quitting in the next 30 days had greater odds of receiving cessation counseling (OR=1.43). As seen in Table 1, smokers who wanted help with quitting, compared with those who did not, had greater odds of receiving every tobacco-related service (Table 1). Similarly, participants in programs with tobacco-free grounds, compared with participants in programs without, had greater odds of receiving three of the five services measured (Table 1).
TABLE 1. Associations of tobacco-related variables and receipt of tobacco cessation services among clients enrolled in 24 addiction treatment programsa
 AskbAdvisecReferralcCounselingcMedicationcCounseling + medicationc
VariableOR95% CIOR95% CIOR95% CIOR95% CIOR95% CIOR95% CI
Current smoker.87.62–1.22nananananananananana
Health distress (reference: low health distress)            
 Mental health distress1.30.94–1.79.83.62–1.12.85.61–1.19.89.69–1.15.85.66–1.09.82.59–1.13
 Physical health distress1.49.95–2.331.26.69–2.301.02.65–1.591.19.73–1.93.63.35–1.13.83.42–1.63
 Mental and physical health distress.95.64–1.41.75.55–1.01.69*.53–.901.05.77–1.43.70.47–1.05.83.57–1.19
Cigarettes per daydnana1.00.99–1.021.011.00–1.031.00.98–1.011.01.99–1.031.01.99–1.03
Quit attempt in past year (reference: no)nana1.17.95–1.431.12.88–1.421.06.81–1.401.04.84–1.291.03.75–1.42
Thinking of quitting in next 30 days (reference: no)nana1.14.90–1.441.18.92–1.521.43*1.11–1.841.32.91–1.911.46.98–2.18
Health risk of smoking to selfdnana1.001.00–1.011.001.00–1.011.001.00–1.011.001.00–1.011.001.00–1.01
Wanted help quitting smoking (reference: no)nana1.55*1.25–1.921.93*1.50–2.481.84*1.40–2.402.64*2.00–3.482.80*1.95–4.04
Tobacco-free grounds (reference: no)1.49*1.08–2.051.76*1.15–2.691.45.97–2.151.90*1.05–3.435.21*1.12–24.263.03.86–10.63
a
Adjusted for age, gender, race or ethnicity, education, time in treatment, treatment type, and nesting of clients within program.
b
Included all participants.
c
Included smokers only.
d
Continuous variable.
*
p≤.05.
These data also may be interpreted by using predicted probabilities, or the probability of receiving a service when the value of the independent variables is known (data not shown). For a smoker who did not want help with quitting and who was not in a program with tobacco-free grounds, the probability of receiving advice on how to quit was 49%. This probability rose to 60% if the smoker wanted help with quitting and to 72% if the same smoker was in a program with tobacco-free grounds. Similarly, the probabilities of receiving tobacco-related counseling were 32% for smokers who did not want help with quitting and who were not in a program with tobacco-free grounds, 46% for those who wanted help with quitting, and 62% if the same smoker attended a program with tobacco-free grounds. Last, the probabilities of receiving tobacco cessation medication in the same three instances were 14%, 29%, and 68%, respectively.

Discussion

Clients who wanted help with quitting smoking reported higher odds of receiving tobacco cessation services. It is possible that clients request cessation services, which are then provided. Increasing client interest in quitting might be done through motivational interviewing (13) or patient empowerment interventions (14), both of which are shown to be effective among smokers younger than 50 who, as in our sample, may not have serious health concerns. Smokers in programs with tobacco-free grounds also had higher odds of being advised to quit and of receiving counseling and medication. This finding is consistent with literature showing increased use of tobacco-related services and greater clinician support of client smoking cessation in addiction treatment programs with tobacco-free grounds (2). Availability of tobacco cessation services may also be greater in programs with tobacco-free grounds. Barriers to tobacco-free grounds policies include staff misconceptions about smoking cessation during addiction treatment. However, staff training may address these barriers and increase client receipt of tobacco services (6). Increasing client motivation to quit and increasing adoption of tobacco-free grounds are feasible low-technology and low-cost strategies to address smoking in addiction treatment.
Study limitations include generalizability because of lack of information about nonrespondents and because programs recruited through the CTN are shown to differ from non-CTN programs (15). The program sample included only publicly funded programs, and participant samples were either U.S. Census based (in residential programs) or convenience samples (in other programs). The cross-sectional design did not permit causal interpretation. The survey did not collect data on psychiatric diagnoses, which may be associated with receipt of tobacco services. Receipt of tobacco-related services was based on self-report and not corroborated by chart review. The study did not collect data on availability of tobacco services in participating programs.

Conclusions

Among clients recruited from addiction programs within a national research network, smoking behavior occurred at an epidemic rate. Robustly associated with receipt of tobacco services were whether the client wanted to quit smoking and whether the program had tobacco-free grounds. Treatment programs may address client smoking in part through interventions that increase motivation to quit. Agencies that fund, license, and regulate such programs should require tobacco-free grounds policies. These steps are necessary to reduce smoking, and related morbidity and mortality, among those who have sought health care in addiction treatment systems.

Acknowledgments

The authors gratefully acknowledge the support of directors who agreed that their program could participate in the study, the program staff who coordinated site visits and data collection, and the clients who gave their time to complete study surveys.

Footnote

The content is solely the responsibility of the authors and does not represent the official views of the National Institutes of Health or the FDA.

References

1.
Key Substance Use and Mental Health Indicators in the United States: Results From the 2016 National Survey on Drug Use and Health. HHS pub no SMA 17-5044, NSDUH Series H-52. Rockville, MD, Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality, 2017
2.
Guydish J, Yip D, Le T, et al: Smoking-related outcomes and associations with tobacco-free policy in addiction treatment, 2015–2016. Drug Alcohol Depend 2017; 179:355–361
3.
Jamal A, Phillips E, Gentzke AS, et al: Current cigarette smoking among adults–United States, 2016. Morb Mortal Wkly Rep 2018; 67:53–59
4.
Bandiera FC, Anteneh B, Le T, et al: Tobacco-related mortality among persons with mental health and substance abuse problems. PLoS One 2015; 10:e0120581
5.
Martínez C, Guydish J, Le T, et al: Predictors of quit attempts among smokers enrolled in substance abuse treatment. Addict Behav 2015; 40:1–6
6.
Knudsen HK: Implementation of smoking cessation treatment in substance use disorder treatment settings: a review. Am J Drug Alcohol Abuse 2017; 43:215–225
7.
Fiore MC, Jaen CR, Baker TB, et al: Treating Tobacco Use and Dependence: 2008 Update. Rockville, MD, US Department of Health and Human Services, 2008
8.
Gerstein DR, Lewin LS: Treating drug problems. N Engl J Med 1990; 323:844–848
9.
Measuring Healthy Days. Atlanta, GA, Centers for Disease Control and Prevention, 2000
10.
DiClemente CC, Prochaska JO, Fairhurst SK, et al: The process of smoking cessation: an analysis of precontemplation, contemplation, and preparation stages of change. J Consult Clin Psychol 1991; 59:295–304
11.
Campbell BK, Le T, Andrews KB, et al: Smoking among patients in substance use disorders treatment: associations with tobacco advertising, anti-tobacco messages, and perceived health risks. Am J Drug Alcohol Abuse 2016; 42:649–656
12.
Campbell BK, Le T, Tajima B, et al: Quitting smoking during substance use disorders treatment: patient and treatment-related variables. J Subst Abuse Treat 2017; 73:40–46
13.
Lindson-Hawley N, Thompson TP, Begh R: Motivational interviewing for smoking cessation. Cochrane Database Syst Rev 2015; 3:CD006936
14.
Weisner CM, Chi FW, Lu Y, et al: Examination of the effects of an intervention aiming to link patients receiving addiction treatment with health care: the LINKAGE clinical trial. JAMA Psychiatry 2016; 73:804–814
15.
Susukida R, Crum RM, Stuart EA, et al: Assessing sample representativeness in randomized controlled trials: application to the National Institute on Drug Abuse Clinical Trials Network. Addiction 2016; 111:1226–1234

Information & Authors

Information

Published In

Go to Psychiatric Services
Go to Psychiatric Services

Cover: XXXX

Psychiatric Services
Pages: 229 - 232
PubMed: 30630403

History

Received: 20 December 2017
Revision received: 20 July 2018
Revision received: 29 October 2018
Accepted: 8 November 2018
Published online: 11 January 2019
Published in print: March 01, 2019

Keywords

  1. Tobacco cessation services
  2. Drug abuse
  3. addiction treatment
  4. psychopharmacology
  5. Public health

Authors

Details

Joseph Guydish, Ph.D. [email protected]
Philip R. Lee Institute for Health Policy Studies, University of California, San Francisco, San Francisco (UCSF) (Guydish, Yip, Le, Gubner, Williams); Department of Psychiatry, UCSF (Delucchi).
Deborah Yip, B.A.
Philip R. Lee Institute for Health Policy Studies, University of California, San Francisco, San Francisco (UCSF) (Guydish, Yip, Le, Gubner, Williams); Department of Psychiatry, UCSF (Delucchi).
Thao Le, M.P.H.
Philip R. Lee Institute for Health Policy Studies, University of California, San Francisco, San Francisco (UCSF) (Guydish, Yip, Le, Gubner, Williams); Department of Psychiatry, UCSF (Delucchi).
Noah R. Gubner, Ph.D.
Philip R. Lee Institute for Health Policy Studies, University of California, San Francisco, San Francisco (UCSF) (Guydish, Yip, Le, Gubner, Williams); Department of Psychiatry, UCSF (Delucchi).
Denise D. Williams, M.A.
Philip R. Lee Institute for Health Policy Studies, University of California, San Francisco, San Francisco (UCSF) (Guydish, Yip, Le, Gubner, Williams); Department of Psychiatry, UCSF (Delucchi).
Kevin L. Delucchi, Ph.D.
Philip R. Lee Institute for Health Policy Studies, University of California, San Francisco, San Francisco (UCSF) (Guydish, Yip, Le, Gubner, Williams); Department of Psychiatry, UCSF (Delucchi).

Notes

Send correspondence to Dr. Guydish ([email protected]).

Competing Interests

The authors report no financial relationships with commercial interests.

Funding Information

National Institute on Drug Abuse10.13039/100000026: P50 DA009253, R01 DA036066
This work was supported by grant number R01 DA036066 from the National Institute on Drug Abuse (NIDA) and the Food and Drug Administration (FDA) Center for Tobacco Products and by NIDA Center grant P50 DA009253.

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

View Options

View options

PDF/EPUB

View PDF/EPUB

Get Access

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - Psychiatric Services

PPV Articles - Psychiatric Services

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share